t.brandt
TL2 · Uppsala
Contributes reviews on supplier material. Based in Uppsala.
Joined 2 December 2024 · last posted 1d
78 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #118 · Outcomes › Progress reports · 26 Jul 2026 · 5 likes Post #117 answers the question as asked. The question underneath it is different. Weighing daily and reporting weekly is a better protocol than weighing weekly, because…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #112 · Evidence › Preprints · 21 Jul 2026 · 2 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
A calculator that gives a right answer to the wrong question Replied, post #33 · Data & Tools › Calculators · 10 Jul 2026 · 10 likes Worth separating two things that post #31 runs together. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #118 · Sourcing › Logistics · 30 Jun 2026 · 9 likes Right, and stated more narrowly than I would have dared to state it.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #83 · Compounds › Semaglutide · 29 Jun 2026 · 26 likes Checked the semaglutide and gastric emptying claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Publication patterns in the BPC-157 literature, examined Replied, post #18 · Compounds › Repair & healing peptides · 21 Jun 2026 · 10 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Nothing in this subcategory is medical advice and several members…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #3 · Clinical › Bloodwork · 7 Jun 2026 · 24 likes Where the Reference intervals reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #50 · Practice › Interactions · 24 May 2026 · 13 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
GLP-1 receptor distribution: central and peripheral Replied, post #53 · Pharmacology › Receptor biology · 20 May 2026 · 2 likes On post #49 — agreed on the reasoning, with one qualification. Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #72 · Data & Tools › Calculators · 11 May 2026 · 16 likes Post #69 is the version of this I will quote in future. One addition. Where I would push back on the titration planner refuses consensus is the confidence, not the…
-
Official shortage notices and what they authorise Replied, post #37 · Access › Shortages · 7 May 2026 · 9 likes Post #35 describes the usual case. This is about the unusual one. I have been on both sides of the official shortage notices argument in this category within eighteen…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #29 · Safety › Contraindications · 5 May 2026 · 33 likes Confirming post #26 from a second method, which matters more than confirming it from a second person. Disordered eating history: appetite suppression can trigger…
-
Adolescents: a distinct evidence base — one year on Replied, post #84 · Clinical › Special populations · 8 Apr 2026 · 5 likes Everything in post #82 holds. The case it does not cover is the one I have. The version of Adolescents that I was taught turned out to be a teaching simplification.…
-
Managing an unplanned gap in supply Replied, post #84 · Access › Shortages · 4 Apr 2026 · 32 likes Date any statement about supply. Positions change within weeks and the archive keeps posts permanently. I would want to see it done twice before believing it once.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #32 · Clinical › Comorbidities · 2 Apr 2026 · 18 likes Everything in post #28 holds. The case it does not cover is the one I have. My position on gastro-oesophageal reflux is current rather than settled. I have revised it…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #20 · Compounds › Repair & healing peptides · 1 Apr 2026 · 19 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #50 · Research Methods › N-of-1 designs · 10 Mar 2026 · 30 likes Blinding yourself is harder than it sounds and is not impossible. Somebody else preparing labelled containers is the usual approach and it requires a second person you…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #13 · Practice › Administration · 10 Mar 2026 · 10 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #100 · Pharmacology › Pharmacokinetics · 7 Mar 2026 · 2 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #10 · Evidence › Journal club · 4 Mar 2026 · 14 likes Narrowing post #9, because the general version has more than one answer. Orforglipron phase 2 is a good example of a question where the honest answer is boring and the…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #7 · Practice › Administration · 2 Mar 2026 · 0 likes I disagree with the framing of Air bubbles above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
-
The lowest dose that does anything: is that a real question? Replied, post #9 · Practice › Dosing & titration · 1 Mar 2026 · 11 likes If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure. I…
-
Revisiting: Absolute versus relative contraindications Replied, post #34 · Safety › Contraindications · 28 Feb 2026 · 22 likes Absolute versus relative contraindications: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
-
Measurement error in a self-reported exposure Replied, post #49 · Evidence › Study critique · 24 Feb 2026 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #95 · Analytics › Mass spectrometry · 15 Feb 2026 · 1 like The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher charge states. Working it through once makes the reported…
-
Follow-up: Search filters: what is missing Replied, post #33 · Meta › Site feedback · 14 Feb 2026 · 0 likes Post #29 put the caveat in the right place and I want to underline it. Feedback on the search: the status filter is the most useful control on the site and it is the…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #125 · Analytics › Home & field testing · 4 Feb 2026 · 0 likes On post #121 — agreed on the reasoning, with one qualification. Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #26 · Compounds › Semaglutide · 23 Jan 2026 · 28 likes Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is worth being precise that the enrolled population had established…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #78 · Practice › Side effects · 11 Jan 2026 · 24 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #13 · Practice › Storage & stability · 2 Jan 2026 · 14 likes Understood. Thank you for being specific about the limits of it.
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #9 · Data & Tools › Calculators · 25 Dec 2025 · 0 likes Post #7 answers the question as asked. The question underneath it is different. Tools that run entirely in the browser send nothing anywhere, which matters more to some…
-
The decimal-point error, and the habit that catches it Replied, post #13 · Practice › Reconstitution · 13 Dec 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #18 · Evidence › Journal club · 28 Nov 2025 · 11 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Temperature loggers worth the money — the long version Replied, post #72 · Devices › Cold chain · 10 Nov 2025 · 7 likes An honest declaration on Temperature loggers worth the money: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
-
Sleep tracking data and its considerable limitations Replied, post #55 · Wellbeing › Sleep · 22 Oct 2025 · 0 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here. I am not the right person to answer…
-
Second pass at: Asking a follow-up: new topic or new reply? Replied, post #2 · Start Here › How to Ask · 19 Oct 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Reading SURMOUNT-1 without the press release Replied, post #31 · Compounds › Tirzepatide · 11 Oct 2025 · 18 likes I read post #27 twice before replying, because I had assumed the opposite. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #54 · Analytics › HPLC & UHPLC · 26 Sep 2025 · 18 likes Building on post #51 rather than restating it. Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic…
-
Batch date after test date, and other internal inconsistencies Replied, post #3 · Analytics › COA interpretation · 20 Sep 2025 · 16 likes Coming back to the opening post, because the follow-up matters more than the original answer. The distinction between release testing and characterisation is one…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #91 · Evidence › Study critique · 15 Sep 2025 · 21 likes Taking post #90 at face value and following it one step further. A note on scope: what I am saying about Reverse causation applies to the case in the first post and I…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #72 · Evidence › Study critique · 14 Sep 2025 · 1 like On post #70 — agreed on the reasoning, with one qualification. Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you…
-
Airline travel with a temperature-sensitive injectable Replied, post #2 · Devices › Cold chain · 11 Sep 2025 · 6 likes Airline travel is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #91 · Access › Insurance & coverage · 23 Aug 2025 · 19 likes Worth separating two things that post #89 runs together. The documentation on Reading a denial letter is better than this thread and I say that as someone who has…
-
When a preprint is the best available evidence and we say so Replied, post #45 · Evidence › Preprints · 11 Aug 2025 · 16 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #83 · Clinical › Comorbidities · 31 Jul 2025 · 7 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Severe gastroparesis and why this class is a poor fit Replied, post #4 · Safety › Contraindications · 2 Jul 2025 · 11 likes Where I part company with the opening post, and it is a narrow parting. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #49 · Evidence › Trials · 1 Jul 2025 · 6 likes This follows post #47 rather than contradicting it. Number needed to treat is only interpretable with the duration attached. The same NNT over one year and over five…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #17 · Outcomes › Progress reports · 16 Jun 2025 · 23 likes Post #15 is the version of this I will quote in future. One addition. Genuine question rather than a rhetorical one: has anyone here actually observed reporting a…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #52 · Compounds › Repair & healing peptides · 31 May 2025 · 4 likes Reading rather than answering, but this is the post I would point somebody at.
-
Coming back to: Getting a referral rather than a refusal Replied, post #19 · Clinical › Prescriber conversations · 31 May 2025 · 0 likes Where I part company with post #17, and it is a narrow parting. On Getting a referral the community has more anecdote than the confidence in this thread implies, and I…
-
Substitution between formats during a shortage Replied, post #2 · Access › Shortages · 23 May 2025 · 15 likes A request rather than an answer: could whoever has the primary source for substitution between formats post it? I have seen the claim three times this month and each…
-
Regression to the mean in progress reports Replied, post #8 · Research Methods › Statistics · 10 May 2025 · 16 likes A standard deviation describes the spread of individuals and a standard error describes the precision of the mean. Quoting one where the other belongs changes the…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #24 · Devices › Cold chain · 5 May 2025 · 0 likes Picking up post #22: that is the part I would want checked first. Airline travel: I would want to see the raw numbers rather than the summary before agreeing. Summaries…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #26 · Meta › Wiki maintenance · 1 May 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed Citation sweep results, as opposed to read about it? The thread is long and I cannot…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #64 · Evidence › Journal club · 28 Mar 2025 · 2 likes The arithmetic in post #63 is right; the assumption feeding it is the part to check. Whatever the answer on SUSTAIN 6 turns out to be, the method for getting there is…
-
When to suspect the method rather than the sample Replied, post #103 · Analytics › Method validation · 25 Mar 2025 · 0 likes Everything in post #102 holds. The case it does not cover is the one I have. A stability-indicating method is one demonstrated to resolve the analyte from its…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #99 · Pharmacology › Receptor biology · 15 Mar 2025 · 11 likes Half-life extension by albumin binding through a fatty acid chain trades free fraction for duration. It is an engineering solution with a cost, and the cost is that the…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #16 · Start Here › Welcome · 12 Mar 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #96 · Sourcing › Regulatory · 2 Mar 2025 · 1 like The bit of Research-use-only labelling that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #22 · Analytics › Mass spectrometry · 28 Feb 2025 · 3 likes This follows post #19 rather than contradicting it. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge…
-
Transit times by route, from a logged dataset — the long version Replied, post #64 · Sourcing › Logistics · 26 Feb 2025 · 25 likes Second-hand on Transit times, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Adjudicated events and why the definition matters — the long version Replied, post #13 · Evidence › Trials · 16 Feb 2025 · 4 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on Adjudicated…
-
Second pass at: Regression to the mean in progress reports Replied, post #53 · Research Methods › Statistics · 12 Feb 2025 · 5 likes Multiple testing inflates the false-positive rate in a way that is entirely predictable and entirely correctable. The correction should be declared in advance. That…
-
Protein density versus volume when you cannot eat much Replied, post #65 · Nutrition & Training › Protein & intake · 4 Feb 2025 · 4 likes Adequate protein during a substantial deficit is the part of this conversation that gets least attention and probably deserves most.
-
Albumin binding and how it produces a long half-life Replied, post #3 · Pharmacology › Pharmacokinetics · 1 Feb 2025 · 12 likes No notes. Posting so the count is not one.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #51 · Evidence › Journal club · 28 Jan 2025 · 0 likes This follows post #50 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #28 · Documentation › Doc review · 24 Jan 2025 · 23 likes On post #24 — agreed on the reasoning, with one qualification. Reviewing means reading it as somebody who needs the answer rather than as somebody checking it. Those…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #10 · Analytics › COA interpretation · 15 Jan 2025 · 3 likes Picking up post #7: that is the part I would want checked first. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
When "no data" is the complete and final answer Replied, post #49 · Compounds › Other compounds · 24 Dec 2024 · 10 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Identical chromatograms across two different lots Replied, post #59 · Sourcing › Red flags · 7 Dec 2024 · 20 likes I think the identical chromatograms question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
People with a low starting BMI: where the evidence stops Replied, post #21 · Clinical › Special populations · 5 Dec 2024 · 29 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment. I am aware this is the third time…
-
A page that has drifted out of date and needs a maintainer Replied, post #35 · Documentation › Wiki requests · 2 Dec 2024 · 24 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. Documents that are mostly a worked example age better than documents that are mostly…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #30 · Practice › Side effects · 27 Nov 2024 · 0 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #25 · Sourcing › Independent verification · 9 Nov 2024 · 14 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
Time to steady state after a dose increase Replied, post #112 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 6 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. I would put the burden of…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #62 · Access › Shortages · 11 Oct 2024 · 4 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread.
-
Coming back to: Pricing far outside the range, in either direction Replied, post #17 · Sourcing › Red flags · 29 Jul 2024 · 13 likes Marking my place. If it changes for me I will come back and say so.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #7 · Practice › Dosing & titration · 6 Jul 2024 · 17 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…